HomeTPST • NASDAQ
add
Tempest Therapeutics Inc
Previous close
$3.17
Year range
$0.17 - $9.77
Market cap
70.35M USD
Avg Volume
1.38M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 7.51M | -15.89% |
Net income | -7.49M | 17.74% |
Net profit margin | — | — |
Earnings per share | -0.34 | 46.03% |
EBITDA | -7.43M | 14.78% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 39.23M | 25.62% |
Total assets | 51.60M | 11.96% |
Total liabilities | 24.84M | -11.23% |
Total equity | 26.77M | — |
Shares outstanding | 22.19M | — |
Price to book | 2.62 | — |
Return on assets | -49.70% | — |
Return on capital | -55.87% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -7.49M | 17.74% |
Cash from operations | -6.18M | 4.69% |
Cash from investing | -7.00K | 98.03% |
Cash from financing | 34.35M | 826.81% |
Net change in cash | 28.17M | 343.64% |
Free cash flow | -3.71M | -1.95% |
About
Founded
2011
Headquarters
Website
Employees
17